0.7955
Schlusskurs vom Vortag:
$0.9069
Offen:
$0.7913
24-Stunden-Volumen:
8.45M
Relative Volume:
9.62
Marktkapitalisierung:
$4.35M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.78M
KGV:
-0.0186
EPS:
-42.6996
Netto-Cashflow:
$-4.67M
1W Leistung:
-21.24%
1M Leistung:
-22.39%
6M Leistung:
-21.24%
1J Leistung:
-42.77%
Clearmind Medicine Inc Stock (CMND) Company Profile
Firmenname
Clearmind Medicine Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CMND mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CMND
Clearmind Medicine Inc
|
0.7955 | 4.96M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Clearmind Medicine Inc Aktie (CMND) Neueste Nachrichten
Is Clearmind Medicine Inc. (CWY0) stock a buy for dividend portfoliosJuly 2025 Spike Watch & Reliable Price Breakout Alerts - newser.com
What momentum shifts mean for Clearmind Medicine Inc.Earnings Recap Summary & Daily Entry Point Alerts - newser.com
Intraday pattern recognizer results for Clearmind Medicine Inc.Market Performance Summary & AI Driven Price Forecasts - newser.com
Will Clearmind Medicine Inc. (CWY0) stock outperform Dow JonesPortfolio Return Summary & High Conviction Investment Ideas - newser.com
What dividend safety score for Clearmind Medicine Inc. stockPortfolio Gains Report & Risk Managed Investment Strategies - newser.com
Is Clearmind Medicine Inc. stock supported by strong fundamentalsWall Street Watch & Community Verified Swing Trade Signals - newser.com
Best data tools to analyze Clearmind Medicine Inc. stockWatch List & Fast Moving Stock Trade Plans - newser.com
Price momentum metrics for Clearmind Medicine Inc. explainedWeekly Gains Report & Smart Swing Trading Techniques - newser.com
What earnings margins imply for Clearmind Medicine Inc. (CWY0) stock2025 Major Catalysts & Fast Exit and Entry Strategy Plans - newser.com
Is Clearmind Medicine Inc. stock positioned for long term growthJuly 2025 Levels & Risk Adjusted Swing Trade Ideas - newser.com
Applying big data sentiment scoring on Clearmind Medicine Inc.Quarterly Risk Review & Long-Term Capital Growth Strategies - newser.com
Clearmind Medicine files patent for cocaine addiction treatment By Investing.com - Investing.com Canada
Clearmind Medicine files patent for cocaine addiction treatment - Investing.com
Clearmind Medicine Advances Fight Against Cocaine Addiction with Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy - The Manila Times
Using data models to predict Clearmind Medicine Inc. stock movementEarnings Trend Report & Breakout Confirmation Alerts - newser.com
Will Clearmind Medicine Inc. (CWY0) stock hit analyst forecastsJuly 2025 Summary & Daily Technical Stock Forecast Reports - newser.com
Why Clearmind Medicine Inc. stock is trending among retail traders2025 Market Outlook & Momentum Based Trading Signals - newser.com
Volatility clustering patterns for Clearmind Medicine Inc.July 2025 Patterns & Free Community Consensus Stock Picks - newser.com
How Clearmind Medicine Inc. stock responds to policy changesJuly 2025 Technicals & Entry Point Strategy Guides - newser.com
Historical volatility pattern of Clearmind Medicine Inc. visualizedJuly 2025 Weekly Recap & Fast Entry and Exit Trade Plans - newser.com
Is Clearmind Medicine Inc. (CWY0) stock inflation resilientJuly 2025 Patterns & Fast Entry and Exit Trade Plans - newser.com
How Clearmind Medicine Inc. (CWY0) stock trades after earningsJuly 2025 Earnings & Reliable Entry Point Alerts - newser.com
Published on: 2025-10-31 00:59:13 - newser.com
Strategies to average down on Clearmind Medicine Inc.Weekly Earnings Recap & High Win Rate Trade Alerts - newser.com
Clearmind Advances Fight Against Cocaine Addiction With Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy - 富途牛牛
Clearmind Medicine Completes First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder - The Manila Times
Clearmind Medicine Inc. Advances Clinical Trial for MEAI-based Therapy Targeting Alcohol Use Disorder - Quiver Quantitative
Clearmind Medicine’s CMND-100: A Promising Study for Alcohol Use Disorder - MSN
Finanzdaten der Clearmind Medicine Inc-Aktie (CMND)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):